disclosures management of opioid use disorders
play

DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS Marc A Schuckit I - PDF document

DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS Marc A Schuckit I have nothing to declare Distinguished Professor of Psychiatry, UCSD Medical School LECTURE COVERS SUDs ARE IMPORTANT Drug groups & problems Affect > 20% of your


  1. DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS Marc A Schuckit I have nothing to declare Distinguished Professor of Psychiatry, UCSD Medical School LECTURE COVERS SUDs ARE IMPORTANT Drug groups & problems Affect > 20% of your patients Substance use disorders Are identified by non-experts Criteria Course Alcohol and drug use ↓ Rx responses Treatment Mimick most psychiatric Dx Identification/intervention Deadly: opioid 33k ODs/yr Detoxification Rehabilitation Opoids cost US > $75 billion/yr After you’re gone 1

  2. LECTURE COVERS DRUG GROUPS Drug groups & problems Substance use disorders Based on: Criteria Usual effects Course Treatment At usual doses Identification/intervention Group then predicts: Detoxification Rehabilitation Pattern of problems After you’re gone DRUG GROUPS THE GOOD, BAD, & UGLY Hallucinogens Depressants Good ↓ pain, cough, shock, diarrhea PCP ↑ euphoria, tranquility, sedation Stimulants Solvents Bad Opioids Tolerance, craving, ↓ respirations Others Cannabinols Ugly: If opioid use disorder Is VERY hard to stop using 2

  3. LECTURE COVERS DRUG PROBLEMS Drug groups & problems Substance use disorders Psychosis Overdose Criteria Course Major depression Treatment Withdrawal Identification/intervention Anxiety Detoxification Delirium Rehabilitation After you’re gone SUBSTANCE USE DISORDER SUD COURSE In same year 2+ of: Fluctuating: Tolerance* Failed roles  Controlled use Withdrawal* Hazardous use Use longer/more  Problems Social problems Unable to ↓  Abstinence Lots time use >20% spontaneous remission ↓ activities Use despite probs In richer & poorer Craving Prevention: NEVER USE FOR A HIGH * Special re opioids 3

  4. LECTURE COVERS OVERDOSE Drug groups & problems Symptoms Substance use disorders Awake respirations <12/min*/stupor*/miosis* Also: ↓ temp/↓ gut sounds/pulmonary edema Criteria Course Treatment Treatment Ventilate Identification/intervention Naloxone: 0.04mg IM, IN, IV— but not oral Detoxification If no ↑ respiration in 2 min →0.5mg Rehabilitation → 2mg → 5mg → 10mg → 15mg After you’re gone Opioid OD Decisions STAGES OF RX Resp < 12min when awake Identification/intervention: drop stereotypes YES NO | O 2 Naloxone Long Acting Opioid? Detoxification Long Acting Opioid? Reassurance Physical exam & history Yes NO Medications Observe 8+hr Yes NO Rehabilitation ICU Observe 6hr ~ p last naloxone Relapse prevention Enhance motivation Continuous Awake/alert Medications IV Naloxone Help readjust to life ± Intubate NO Yes Aftercare Observe 6hr ICU ~ Refer for OP Rx p IV stop Boyer NEJM 2012 4

  5. TO ID: ASK ABOUT PROBLEMS QUESTIONNAIRES Legal Relationships CAGE-AID (2+): Feel need cut down Feel bad or guilty Health School or job Annoyed by criticisms Eye-opener for relief/steady Accidents Drug Use Questionnaire (DAST-10: 3+) Then tie in substances Non-med use/multi drugs/not stop/blackout/guilt/ Complaints/neglect/illegal/withdrawal/med probs MOTIVATIONAL INTERVIEWING STAGES OF RX Build trust Identification/intervention Empathic Detoxification Avoid ↑ resistance Physical exam & history Reassurance Vitamins Medications Patient is in charge Rehabilitation Elicit motivational statements Enhance motivation Relapse prevention Help readjust to life Explore ambivalence Medications Monitor readiness to change Aftercare 5

  6. DETOX RX DETOX Physical exam Rest & education Depressants Nutrition Opioids Meds for: Stimulants (no specific Rx) Opioids KEY MEDICATIONS OPIOID WITHDRAWAL Methadone (oral): Symptoms opposite of acute effects Mu-opioid agonist; ½ life 15-20 hrs Timing depends on drug length action Buprenorphine (SL or buccal) Partial mu agonist; kappa antagonist PE, educate, motivate ½ life 3 hrs (longer recepter occupation) Methadone or Mu antagonists: Naltrexone ½ life: oral 4-13 hrs IM 5-10 days Naloxone (not oral): onset 2 min; action 20-90 min Buprenorphene 6

  7. CLINICAL OPIOID WITHDRAWAL WITHDRAWAL SCALE (COWS) Detox ≠ rehabilitation Pulse > 80 Rhinorrhea Sweating Cramps/naus/vomit Onset symptoms Restless Tremor Naloxone: in 2 minutes Pupils ↑ Yawning Short acting (heroin): ~ 8 hrs, ↓ day 4 Bone/joint pain Anxous/irritable Long acting (methadone): 1+ days, ↓ day 10 Goosebumps Each scored 1-4 or 1-5 Protracted withdrawal: 2 weeks to 2+ months Total: 5-12 = mild 25-36 = mod/severe Fatigue ↓ appetite insomnia anhedonia 13-24 = mod > 36 = severe LONG ACTING OPIOID TAPER OPIOID-FREE DETOX Med Dose Target Oral methadone SL buprenorphine Clonidine 0.1-0.2mg q 4h Flu-like PE PE: Rx at mild sympt patch 1 for 100-200 # Initial dose (ck in 1 hr; adjust) 10 mg < current dose 4-8 mg Diazepam 2-10mg q 4h Insom/anxiety 10-30 mg/d (÷) Stabilize Imodium 4mg, then 2mg Diarrhea 7-14 days 2-5 days Taper Naproxin 500mg 2x/d Aches/pain ~ 0-20% of initial dose Compazine 5-10mg q 4h Naus/vomit Every 1-2 days 7

  8. STAGES OF RX REHABILITATION Identification/intervention Increase motivation Detoxification Physical exam & history Reassurance Help rebuild life Vitamins Medications Rehabilitation Relapse prevention Enhance motivation Relapse prevention Medications Help readjust to life +/- medications Aftercare REHAB: NALTREXONE MAINTENANCE GOALS Action: Blocks opioid high/↓ craving Substitute safer opioid Oral to avoid craving set on by needles Restriction: Must be opioid free Long acting to avoid daytime symptoms Use 1+ years— note OD danger when stop Induction: Test : 12.5mg; in 4 h 25-50mg Rx includes counseling pain control Day 1: Begin 50-100mg/d monitoring Goals: ↓ IV dangers ↑ Health Maintenance: 100mg Mon & Wed Crime Work 150mg Fri OD Relationships OR 380mg IM/mo 8

  9. REHAB: BUPRINORPHINE REHAB:METHADONE Action: SL/buccal long ½ life opioid Action: Oral & long ½ life opioid & naloxone (4 to 1 ratio) Restriction: Only in special clinics Restriction: Trained pvt doc office OK Induction: 1-2 wk:15-30mg Induction: Wk 1-8: 4-8mg/d up to 16-32mg ↑ 10-50mg ~q 5d to 50-100mg Maintenance: Dose on SE and craving Maintenance: Consider take-home weekend dose if adherent to Rx at 8 wk CBT ↓ dysfunctional thoughts (must have drugs) ↑ rational thoughts (I can change) Relapse prevention (risk never ends) Anticipate triggers Learn to cope w/triggers Change behaviors (sober friends; ↓ stress) 9

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend